<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02715466</url>
  </required_header>
  <id_info>
    <org_study_id>HC-G-H-1209</org_study_id>
    <nct_id>NCT02715466</nct_id>
  </id_info>
  <brief_title>Gelatin in ICU and Sepsis</brief_title>
  <acronym>GENIUS</acronym>
  <official_title>Prospective, Controlled, Double-Blind, Randomized Multicentric Study On The Efficacy And Safety Of An Early Target Controlled Plasma Volume Replacement Therapy With A Balanced Gelatine Solution vs A Balanced Electrolyte Solution In Patients With Severe Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>B. Braun Melsungen AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>B. Braun Melsungen AG</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective, double-blind randomized controlled trial evaluates the differences in terms
      of efficacy and safety of gelatin based resuscitation as compared to crystalloid based
      resuscitation in two parallel groups of patients with severe sepsis / septic shock.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time until first/initial hemodynamic stabilization</measure>
    <time_frame>48 hours after treatment start</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of stay (LOS) in the intensive care unit (ICU)</measure>
    <time_frame>Intensive care unit (ICU) discharge or day 28</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">608</enrollment>
  <condition>Hypovolemia</condition>
  <arm_group>
    <arm_group_label>Gelatine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Balanced gelatine solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Electrolyte</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Balanced electrolyte solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Balanced gelatine solution</intervention_name>
    <description>Gelaspan combined with Sterofundin ISO</description>
    <arm_group_label>Gelatine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Balanced electrolyte solution</intervention_name>
    <description>Sterofundin ISO</description>
    <arm_group_label>Electrolyte</arm_group_label>
    <arm_group_label>Gelatine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female patients ≥ 18 and ≤ 85 years of age

          -  Women of child bearing potential must test negative on standard pregnancy test (urine
             or serum)

          -  Patients with body weight ≥ 55 kg and ≤ 140 kg and body mass index (BMI) ≥ 18 kg/m2

          -  Patients diagnosed severe sepsis / septic shock at admission on Intensive Care Unit
             who can be enrolled within 90 min after admission OR patients diagnosed severe sepsis
             / septic shock during Intensive Care Unit stay who can be enrolled within 90 min after
             diagnosis

          -  Patients where antibiotic therapy has already been started (prior to randomization)

          -  Patient who are fluid responsive. Fluid responsiveness is defined as increase of &gt; 10%
             in mean arterial pressure (MAP) after passive leg raising (PLR)

          -  Signed informed consent by patient, legal representative or authorized person or
             deferred consent

        Exclusion Criteria:

          -  Administration of HES, dextrane solutions or &gt; 500 ml of Gelatin solutions within the
             24 h prior to randomization

          -  Death expected within the next 48 h (moribund patients as defined by ASA ≥ class V)

          -  Patients whose medical condition does preclude the PLR manoeuvre

          -  Patients for whom the need of pressure infusions are expected

          -  Requirement for renal support (either continuous or discontinuous techniques,
             including intermittent haemodialysis, haemofiltration and haemodiafiltration)

          -  Patients receiving therapeutic heparin medication due to chronic coagulation disease /
             anticoagulation medication (i.e. partial thromboplastin time &gt; 60 sec)

          -  Acutely burned patients

          -  Contraindications according to summary of product characteristics of investigational
             test and reference product

          -  Simultaneous participation in another interventional clinical trial (drugs or medical
             devices studies)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gernot Marx, Prof. Dr. med.</last_name>
    <role>Study Chair</role>
    <affiliation>Universitätsklinikum Aachen,Klinik für Operative Intensivmedizin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Study Manager</last_name>
    <phone>+49-5661-71-0</phone>
    <email>studies@bbraun.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medizinische Universität Innsbruck</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dietmar Fries, Prof. Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fakultní nemocnice Hradec Králové</name>
      <address>
        <city>Hradec Králové</city>
        <zip>50005</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Masarykova nemocnice v Ústí nad Labem, o.z.</name>
      <address>
        <city>Ústí nad Labem</city>
        <zip>401 13</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vladimír Černý, Prof. MUDr., PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Université de Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Hôpital Pasteur 2 - CHU de Nice</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gernot Marx, Univ.-Prof. Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Bremen-Mitte</name>
      <address>
        <city>Bremen</city>
        <zip>28177</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rolf Dembinski, Prof. Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Frankfurt</name>
      <address>
        <city>Frankfurt am Main</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kai Zacharowski, Univ.-Prof. Dr. Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsinstitut - Johannes Wesling Klinikum MInden</name>
      <address>
        <city>Minden</city>
        <zip>32427</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernd Bachmann-Mennenga, Prof. Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Rostock</name>
      <address>
        <city>Rostock</city>
        <zip>18057</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tobias Schuerholz, Prof. Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Tübingen</name>
      <address>
        <city>Tuebingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Szegedi Tudományegyetem - Általános Orvostudományi Kar</name>
      <address>
        <city>Szeged</city>
        <zip>6725</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ricard Ferrer, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuel Sanchez, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen Macarena</name>
      <address>
        <city>Sevilla</city>
        <zip>41009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>José Garnacho Montero, Dr. med.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Czechia</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Spain</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>March 17, 2016</study_first_submitted>
  <study_first_submitted_qc>March 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 22, 2016</study_first_posted>
  <last_update_submitted>January 9, 2020</last_update_submitted>
  <last_update_submitted_qc>January 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypovolemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

